DR6


Manufacturer	GENWAY
Category	Oncology Antibodies Flow Cytometry Immunoprecipitation Primary Antibodies By Organ Bone Cancer
Type	Antibody
Specific against	other
Clone	DR-06-04-EC
Applications	FC, IP
Amount	0.025 mg
Item no.	20-783-310381
eClass 6.1	32160702
eClass 9.0	32160702
Available
Genway ID:	GWB-98A8D3
Specificity:	DR6NCBI
Gene ID:	27242
Specificity:	DR6
Clone:	DR-06-04-EC
Immunogen:	Fusion protein containing the extracellular region of DR6 (amino acids 42-335)
Fusion Partner:	Spleen cells from immunised F1 hybrid mice were fused with cells of the SP2/0-Ag14 myeloma cell line.
Preparation:	Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Buffer Solution:	Phosphate buffered saline pH7. 4
Preservative Stabilisers:		0. 09%Sodium AzideSuggested
Flow Cytometry:	Use 10ul of the suggested working dilution to label 106 cells in 100ul.
Function:	May activate NF-kappa-B and JNK and promote apoptosis.
Subunit:	Associates with TRADD.
Subcellular Location:	Membrane; Single-pass type I membrane protein (Probable).
Tissue Specificity:	Highly expressed in heart brain placenta pancreas lymph node thymus and prostate. Detected at lower levels in lung skeletal muscle kidney testis uterus small intestine colon spleen bone marrow and fetal liver. Very low levels were found in adult liver and peripheral blood leukocytes.
Similarity:	Contains 1 death domain.
Similarity:	Contains 4 TNFR-Cys repeats.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.025 mg

available

Delivery expected until 5/9/2024